SPONSOR
Institute of Oncology Ljubljana
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Gynecologic CancerUrologic CancerBreast CancerVascular MalformationsMetastatic MelanomaSkin CancerColon Cancer
Institute of Oncology Ljubljana is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Gynecologic Cancer, Urologic Cancer, Breast Cancer, Vascular Malformations.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institute of Oncology Ljubljana
How many clinical trials has Institute of Oncology Ljubljana sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Institute of Oncology Ljubljana, of which 5 are actively recruiting participants. These trials cover conditions including Gynecologic Cancer, Urologic Cancer, Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institute of Oncology Ljubljana research focus on?
Institute of Oncology Ljubljana clinical trials span Gynecologic Cancer, Urologic Cancer, Breast Cancer, Vascular Malformations, Metastatic Melanoma, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institute of Oncology Ljubljana clinical trial?
To participate in a Institute of Oncology Ljubljana trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institute of Oncology Ljubljana trials with current recruitment status updated daily.
Clinical Trials by Institute of Oncology Ljubljana
NCT07416630
Recruiting
Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients
Gynecologic Cancer
NCT07418125
Recruiting
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
Breast Cancer
NCT07579962 Phase 2
Recruiting
Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST)
Vascular Malformations
NCT07422779
Recruiting
Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia
Metastatic Melanoma
NCT06923787 Phase 2
Recruiting
Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study
Colon Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology